stability of bpc-157 in aqueous solution at room temperature BPC157 BPC-157 Stability: Storage & Reconstitution

Doses Per Vial Vial duration varies by dose escalation phase: 3mg vial: At 0.25mg/week = 12 weeks At 0.5mg/week = 6 weeks At 1mg/week = 3 weeks At 2.4mg/week = 1.25 weeks 5mg vial: At 0.25mg/week = 20 weeks At 0.5mg/week = 10 weeks At 1mg/week = 5 weeks At 1.7mg/week = ~3 weeks At 2.4mg/week = ~2 weeks A 5mg vial can cover the entire first 4 months of a slow escalation protocol starting at 0.25mg

The micro-channels created allow topical GHK-CU to reach deeper dermal layers where it can stimulate collagen production more effectively

For that reason, compare the total contents with your injection schedule rather than judging value by vial count alone

GLP-1 medications are typically dosed weekly (semaglutide, tirzepatide) while BPC-157 is dosed daily